Gapping up
News:
- BTAI +32.8% (Announces Positive FDA Pre-sNDA Meeting Comments for sNDA Submission for BXCL501 in Agitation Associated with Bipolar Disorders or Schizophrenia)
- EM +16.6% (announces receipt of a preliminary non-binding proposal to acquire the company from Hillhouse)
- SHCO +16% (signs definitive take-private agreement; Holders of common stock of the Company will receive $9.00/share in cash)
- TNXP +6.7% (resumes trading and spikes higher by 20% in after-hours action after announcing before the close that the FDA granted approval of Tonmya (cyclobenzaprine HCl sublingual tablets) for the treatment of Fibromyalgia)
- FFAI +5.4% (Launches its "EAI + Crypto" Dual-Flywheel & Dual-Bridge Ecosystem Strategy; Provides Livestream Information for its Major Strategy Upgrade Announcement on August 16th)
- VNDA +5.3% (appeals court overturns FDA's order denying approval of Hetlioz for the treatment of jet lag disorder)
- NVO +3.1% (FDA approves a new indication for Wegovy; approved for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis)
- SAFX +3.1% (to delay 10-Q filing)
- ENTG +3.1% (New Duquesne (Stanley Druckenmiller) position)
- LUMN +2.9% (CFO disclosed Friday the purchase of 82,000 shares at $4.20 - $4.53 worth about $358K)
- FGEN +2.9% (announces that the China State Administration for Market Regulation approved the sale of FibroGen International to AstraZeneca (AZN) Treasury Limited)
- WULF +2.7% (announces that Fluidstack exercised its option to expand at the company's Lake Mariner data center campus; intends to offer $400 mln aggregate principal amount of convertible senior notes due 2031) EU +1.8% (expands Alta Mesa Uranium Project)
- MITT +1.6% (files for 2,027,676 share common stock offering by selling shareholders)
- JRVR +1.4% (files for 21,334,134 share common stock offering by selling shareholders)
- ENLT +1.3% (provided updates for IRS changes)
- FSM +1.2% (drills 4.5 g/t Au over 37.4 meters at Kingfisher and 11.2 g/t Au over 5.6 meters at Sunbird)
- GCT +1.1% (authorized new share repurchase program of $111 mln of Class A ordinary shares over the next three years)